Livzon Pharmaceutical Group Inc. (HKG:1513)

HKG:1513 Revenue

Livzon Pharmaceutical Group had revenue of 2.80B CNY in the quarter ending September 30, 2024, a decrease of -5.59%. This brings the company's revenue in the last twelve months to 11.86B, down -7.34% year-over-year. In the year 2023, Livzon Pharmaceutical Group had annual revenue of 12.43B, down -1.58%.

• Revenue (ttm): 11.86B CNY
• Revenue Growth: -7.34%
• P/S Ratio: n/a
• Revenue / Employee: 1.33M CNY
• Employees: 8,933
• Market Cap: 29.46B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	12.43B	-199.54M	-1.58%
Dec 31, 2022	12.63B	565.72M	4.69%
Jan 1, 2022	12.06B	1.54B	14.67%
Jan 1, 2021	10.52B	1.14B	12.10%
Jan 1, 2020	9.38B	524.04M	5.91%